Homepage - Scipher Medicine
Powerful & Proprietary Platform. We combined the mapping of hundreds of thousands of protein interactions in human cells, one of the largest molecular data registries in autoimmune diseases, and unique AI algorithms to create solutions that help patients reach their treatment goals sooner.
Company - Scipher Medicine
Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy and bring forward the day when every autoimmune disease patient reaches remission, and no one suffers in silence.
Platform - Scipher Medicine
Built upon over a decade of experimental research, the platform’s backbone is the network map of human biology explaining how proteins expressed from the human genome interact to cause specific disease phenotypes, providing the wiring diagram needed to interpret dynamic individual patient molecular data to reveal actual disease biology.
Solutions - Scipher Medicine
Using a proprietary combination of network science and AI, Spectra maps autoimmune diseases at the molecular level identifying the molecular signature in order to find the appropriate treatment path for each patient.
Scipher Medicine Announces Publication of Real-World Study ...
Feb 1, 2022 · The real-world results show that patients with rheumatoid arthritis (RA) have significantly improved clinical response when PrismRA is used to select treatment. PrismRA is the only blood test in the market informing personalized treatment decisions for patients with RA.
Scipher Medicine Acquires CrossBridge and its SaaS Platform to …
WALTHAM, Mass. (January 10, 2023) – ScipherMedicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities.
Latest - Scipher Medicine
Jul 30, 2024 · Scipher Medicine® Launches a New Approach to Discover Treatment-Response-Predicting Biomarkers for Complex Diseases. Jul 30, 2024
Careers - Scipher Medicine
We’re focused on outcomes, not when and where you do your work. We pay 100% of dental, health, vision, life, and disability premiums for employees and their families. We also pay 50% of your annual deductible. We’ll match up to 4% of your 401K contributions with no vesting.
Scipher Medicine Closes $110 Million Financing
Feb 24, 2022 · Scipher is bringing precision medicine to patients with autoimmune diseases by commercializing blood tests that reveal a person’s unique molecular disease signature and matching it to the most effective existing therapy, ensuring providers and payers can select optimal therapy from day one.
Scipher Medicine Announces $82 Million Financing
Mar 23, 2021 · Scipher Medicine Announces $82 Million Financing. -aMoon and Northpond Ventures led the round. -Additional investors include Echo Health Ventures, Khosla Ventures and Alumni Ventures. -Financing will support commercialization of precision medicine PrismTM portfolio of blood tests and data partnerships in autoimmune diseases with payers ...